<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shen</surname>
    <given-names>ZX</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>GQ</given-names>
   </name>
   <name>
    <surname>Ni</surname>
    <given-names>JH</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>XS</given-names>
   </name>
   <name>
    <surname>Xiong</surname>
    <given-names>SM</given-names>
   </name>
   <name>
    <surname>Qiu</surname>
    <given-names>QY</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>GL</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>KQ</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients</article-title>
  <source>Blood</source>
  <year>1997</year>
  <volume>89</volume>
  <issue>9</issue>
  <fpage>3354</fpage>
  <lpage>3360</lpage>
  <pub-id pub-id-type="doi">10.1182/blood.V89.9.3354</pub-id>
  <?supplied-pmid 9129042?>
  <pub-id pub-id-type="pmid">9129042</pub-id>
 </element-citation>
</ref>
